Expanding Vascepa Markets and EPA Generics

The approval of Amarin’s Vascepa Iscosapentyl Ethyl (97% EPA EE) in the United States launched a new, effective treatment for cardiovascular diseases (CVD).  According to a report by Jefferies India,  Amarin sold over 500 million Vascepa capsules in the United...
By :
Comments : Off